Predicting survival of patients with idiopathic pulmonary fibrosis using GAP score: a nationwide cohort study
Open accessThe DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
The clinical course of idiopathic pulmonary fibrosis (IPF) varies widely. Although the GAP model is useful for predicting mortality, survivals have not yet been validated for each GAP score. We aimed to elucidate how prognosis is related to GAP score and GAP stage in IPF patients. The Korean Interstitial Lung Disease Study Group conducted a national survey to evaluate various characteristics in IPF patients from 2003 to 2007. Patients were diagnosed according to the 2002 criteria of the ATS/ERS. We enrolled 1,685 patients with IPF; 1,262 had undergone DL CO measurement. Patients were stratified based on GAP score (0–7): GAP score Group 0 ( n = 26), Group 1 ( n = 150), Group 2 ( n = 208), Group 3 ( n = 376), Group 4 ( n = 317), Group 5 ( n = 138), Group 6 ( n = 39), and Group 7 ( n = 8). Higher GAP score and GAP stage were associated with a poorer prognosis ( p < 0.001, respectively). Survival time in Group 3 was lower than those in Groups 1 and 2 ( p = 0.043 and p = 0.039, respectively), and higher than those in groups 4, 5, and 6 ( p = 0.043, p = 0.032, and p = 0.003, respectively). Gender, age, and DL CO (%) differed significantly between Groups 2 and 3. All four variables in the GAP model differed significantly between Groups 3 and 4. The GAP system showed significant predictive ability for mortality in IPF patients. However, prognosis in IPF patients with a GAP score of 3 were significantly different from those in the other stage I groups and stage II groups of Asian patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.165.2.ats01 · Cited by 4,196
Clinical course and prediction of survival in idiopathic pulmonary fibrosis
Ley, B., Collard, H. R., & King, T. E. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201006-0894ci · Cited by 1,765 · cited 2×
“The most common cause of death in IPF patients is respiratory failure, which results from the progression of lung fibrosis, rather than comorbidities [3].”
BackgroundA Multidimensional Index and Staging System for Idiopathic Pulmonary Fibrosis
Ley, B., Ryerson, C. J., Vittinghoff, E., Ryu, J. H., Tomassetti, S., Lee, J. S., Poletti, V., Buccioli, M., Elicker, B. M., Jones, K. D., et al. (2012) · Annals of Internal Medicine · doi:10.7326/0003-4819-156-10-201205150-00004 · Cited by 1,308
Self-citationWells, A. U., Desai, S. R., Rubens, M. B., Goh, N. S. L., Cramer, D., Nicholson, A. G., Colby, T. V., du Bois, R. M., & Hansell, D. M. (2003) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.2111053 · Cited by 686 · cited 2×
“This might be explained by a difference in study design between the GAP model and CPI: GAP uses more clinical data in its model, such as age and gender, while CPI was created using only PFT results [12, 14].”
MethodResultPredicting Survival Across Chronic Interstitial Lung Disease
Ryerson, C. J., Vittinghoff, E., Ley, B., Lee, J. S., Mooney, J. J., Jones, K. D., Elicker, B. M., Wolters, P. J., Koth, L. L., King, T. E., et al. (2014) · Chest · doi:10.1378/chest.13-1474 · Cited by 558 · cited 2×
“with chronic ILD (ILD-GAP model) and IPF related to occupational dust exposure [26, 28].”
BackgroundMethodSelf-citationPeripheral blood proteins predict mortality in idiopathic pulmonary fibrosis
Richards, T. J., Kaminski, N., Baribaud, F., Flavin, S., Brodmerkel, C., Horowitz, D., Li, K., Choi, J., Vuga, L. J., Lindell, K. O., et al. (2012) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201101-0058oc · Cited by 381 · cited 1×
“[22] used biomarkers to create another predictive model.”
MethodSkeletal Muscle Apoptosis and Weight Loss in Chronic Obstructive Pulmonary Disease
Agustí, A. G. N., Sauleda, J., Miralles, C., Gomez, C., Togores, B., Sala, E., Batle, S., & Busquets, X. (2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.2108013 · Cited by 343
Cited by
Lee, S. H., Park, J. S., Kim, S. Y., Kim, D. S., Kim, Y. W., Chung, M. P., Uh, S. T., Park, C. S., Park, S. W., Jeong, S. H., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-23073-3 · Cited by 50
Self-citationUnderlying and immediate causes of death in patients with idiopathic pulmonary fibrosis
Kärkkäinen, M., Nurmi, H., Kettunen, H.-P., Selander, T., Purokivi, M., & Kaarteenaho, R. (2018) · BMC Pulmonary Medicine · doi:10.1186/s12890-018-0642-4 · Cited by 38
Comparison of disease progression subgroups in idiopathic pulmonary fibrosis
Kärkkäinen, M., Kettunen, H.-P., Nurmi, H., Selander, T., Purokivi, M., & Kaarteenaho, R. (2019) · BMC Pulmonary Medicine · doi:10.1186/s12890-019-0996-2 · Cited by 23
Metadata
- Authors
- Lee, S. H., Kim, S. Y., Kim, D. S., Kim, Y. W., Chung, M. P., Uh, S. T., Park, C. S., Jeong, S. H., Park, Y. B., Lee, H. L., Shin, J. W., Lee, E. J., Lee, J. H., Jegal, Y., Lee, H. K., Kim, Y. H., Song, J. W., Park, S. W., & Park, M. S.
- Venue
- Respiratory Research
- Published
- 2016-10-18
- Volume
- 17
- Issue
- 1
- Pages
- 131-131
- ISSN
- 1465-9921 (ISSN-L)
- 1465-993X
- OpenAlex
- W2533864328
- Cited by
- 68
- References
- 7
- FWCI
- 3.97
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Predicting survival of patients with idiopathic pulmonary fibrosis using GAP score: a nationwide cohort study. https://app.cochat.ai/papers/10.1186/s12931-016-0454-0
- The paper
- Lee, S. H., Kim, S. Y., Kim, D. S., Kim, Y. W., Chung, M. P., Uh, S. T., Park, C. S., Jeong, S. H., Park, Y. B., Lee, H. L., Shin, J. W., Lee, E. J., Lee, J. H., Jegal, Y., Lee, H. K., Kim, Y. H., Song, J. W., Park, S. W., & Park, M. S. (2016). Predicting survival of patients with idiopathic pulmonary fibrosis using GAP score: a nationwide cohort study. Respiratory Research. https://doi.org/10.1186/s12931-016-0454-0
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.